We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
235 hedge funds and large institutions have $306M invested in Sorrento Therapeutics, Inc. in 2022 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 89 increasing their positions, 37 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
283% more call options, than puts
Call options by funds: $14.4M | Put options by funds: $3.76M
141% more repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 37
11% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 37
0% more funds holding
Funds holding: 234 → 235 (+1)
29% less capital invested
Capital invested by funds: $432M → $306M (-$127M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
235
Holders Change
+1
Holders Change %
+0.43%
% of All Funds
3.71%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
41
Increased
89
Reduced
37
Closed
37
Calls
$14.4M
Puts
$3.76M
Net Calls
+$10.7M
Net Calls Change
-$13.4M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$60.4M |
| 2 |
D.E. Shaw & Co
New York
|
+$15M |
| 3 |
Morgan Stanley
New York
|
+$7.38M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$5.17M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.09M |
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$10.2M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$1.74M |
| 3 |
Barclays
London,
United Kingdom
|
-$1.02M |
| 4 |
Citigroup
New York
|
-$1.02M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$982K |
